242 related articles for article (PubMed ID: 10075013)
1. Signalling of Bruton's tyrosine kinase, Btk.
Mohamed AJ; Nore BF; Christensson B; Smith CI
Scand J Immunol; 1999 Feb; 49(2):113-8. PubMed ID: 10075013
[TBL] [Abstract][Full Text] [Related]
2. Bruton tyrosine kinase (BTK) in X-linked agammaglobulinemia (XLA).
Vihinen M; Mattsson PT; Smith CI
Front Biosci; 2000 Dec; 5():D917-28. PubMed ID: 11102316
[TBL] [Abstract][Full Text] [Related]
3. B-cell antigen receptor stimulation activates the human Bruton's tyrosine kinase, which is deficient in X-linked agammaglobulinemia.
de Weers M; Brouns GS; Hinshelwood S; Kinnon C; Schuurman RK; Hendriks RW; Borst J
J Biol Chem; 1994 Sep; 269(39):23857-60. PubMed ID: 7929028
[TBL] [Abstract][Full Text] [Related]
4. Regulation of B lymphocyte development and activation by Bruton's tyrosine kinase.
Khan WN
Immunol Res; 2001; 23(2-3):147-56. PubMed ID: 11444380
[TBL] [Abstract][Full Text] [Related]
5. Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA).
Zhu Q; Zhang M; Rawlings DJ; Vihinen M; Hagemann T; Saffran DC; Kwan SP; Nilsson L; Smith CI; Witte ON; Chen SH; Ochs HD
J Exp Med; 1994 Aug; 180(2):461-70. PubMed ID: 7519238
[TBL] [Abstract][Full Text] [Related]
6. Rapid tyrosine phosphorylation and activation of Bruton's tyrosine/Tec kinases in platelets induced by collagen binding or CD32 cross-linking.
Oda A; Ikeda Y; Ochs HD; Druker BJ; Ozaki K; Handa M; Ariga T; Sakiyama Y; Witte ON; Wahl MI
Blood; 2000 Mar; 95(5):1663-70. PubMed ID: 10688822
[TBL] [Abstract][Full Text] [Related]
7. Mutation analysis of the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia: identification of a mutation which affects the same codon as is altered in immunodeficient xid mice.
de Weers M; Mensink RG; Kraakman ME; Schuurman RK; Hendriks RW
Hum Mol Genet; 1994 Jan; 3(1):161-6. PubMed ID: 8162018
[TBL] [Abstract][Full Text] [Related]
8. Role of Bruton's tyrosine kinase in B cell development.
Maas A; Hendriks RW
Dev Immunol; 2001; 8(3-4):171-81. PubMed ID: 11785667
[TBL] [Abstract][Full Text] [Related]
9. Bruton's tyrosine kinase expression and activity in X-linked agammaglobulinaemia (XLA): the use of protein analysis as a diagnostic indicator of XLA.
Gaspar HB; Lester T; Levinsky RJ; Kinnon C
Clin Exp Immunol; 1998 Feb; 111(2):334-8. PubMed ID: 9486400
[TBL] [Abstract][Full Text] [Related]
10. Complementary roles for CD19 and Bruton's tyrosine kinase in B lymphocyte signal transduction.
Fujimoto M; Poe JC; Satterthwaite AB; Wahl MI; Witte ON; Tedder TF
J Immunol; 2002 Jun; 168(11):5465-76. PubMed ID: 12023340
[TBL] [Abstract][Full Text] [Related]
11. BTK, the tyrosine kinase affected in X-linked agammaglobulinemia.
Vihinen M; Mattsson PT; Smith CI
Front Biosci; 1997 Jan; 2():d27-42. PubMed ID: 9159207
[TBL] [Abstract][Full Text] [Related]
12. Bruton's tyrosine kinase is required for activation of IkappaB kinase and nuclear factor kappaB in response to B cell receptor engagement.
Petro JB; Rahman SM; Ballard DW; Khan WN
J Exp Med; 2000 May; 191(10):1745-54. PubMed ID: 10811867
[TBL] [Abstract][Full Text] [Related]
13. Unimpaired activation of c-Jun NH2-terminal kinase (JNK) 1 upon CD40 stimulation in B cells of patients with X-linked agammaglobulinemia.
Brunner C; Kreth HW; Ochs HD; Schuster V
J Clin Immunol; 2002 Jul; 22(4):244-51. PubMed ID: 12148599
[TBL] [Abstract][Full Text] [Related]
14. Genomic organization of mouse and human Bruton's agammaglobulinemia tyrosine kinase (Btk) loci.
Sideras P; Müller S; Shiels H; Jin H; Khan WN; Nilsson L; Parkinson E; Thomas JD; Brandén L; Larsson I
J Immunol; 1994 Dec; 153(12):5607-17. PubMed ID: 7989760
[TBL] [Abstract][Full Text] [Related]
15. Functions of Bruton's tyrosine kinase in mast and B cells.
Kawakami Y; Kitaura J; Hata D; Yao L; Kawakami T
J Leukoc Biol; 1999 Mar; 65(3):286-90. PubMed ID: 10080529
[TBL] [Abstract][Full Text] [Related]
16. Role of Bruton's tyrosine kinase in immunodeficiency.
Tsukada S; Rawlings DJ; Witte ON
Curr Opin Immunol; 1994 Aug; 6(4):623-30. PubMed ID: 7946052
[TBL] [Abstract][Full Text] [Related]
17. Six X-linked agammaglobulinemia-causing missense mutations in the Src homology 2 domain of Bruton's tyrosine kinase: phosphotyrosine-binding and circular dichroism analysis.
Mattsson PT; Lappalainen I; Bäckesjö CM; Brockmann E; Laurén S; Vihinen M; Smith CI
J Immunol; 2000 Apr; 164(8):4170-7. PubMed ID: 10754312
[TBL] [Abstract][Full Text] [Related]
18. X-chromosome inactivation and mutation pattern in the Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinemia. Italian XLA Collaborative Group.
Moschese V; Orlandi P; Plebani A; Arvanitidis K; Fiorini M; Speletas M; Mella P; Ritis K; Sideras P; Finocchi A; Livadiotti S; Rossi P
Mol Med; 2000 Feb; 6(2):104-13. PubMed ID: 10859027
[TBL] [Abstract][Full Text] [Related]
19. Cutting edge: CD40 engagement eliminates the need for Bruton's tyrosine kinase in B cell receptor signaling for NF-kappa B.
Mizuno T; Rothstein TL
J Immunol; 2003 Mar; 170(6):2806-10. PubMed ID: 12626529
[TBL] [Abstract][Full Text] [Related]
20. Bruton's tyrosine kinase defect in dendritic cells from X-linked agammaglobulinaemia patients does not influence their differentiation, maturation and antigen-presenting cell function.
Gagliardi MC; Finocchi A; Orlandi P; Cursi L; Cancrini C; Moschese V; Miyawaki T; Rossi P
Clin Exp Immunol; 2003 Jul; 133(1):115-22. PubMed ID: 12823285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
